[On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid)].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D007611:Aprotinin / Q000494:pharmacology*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D003331:Coronary Vessels; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D004285:Dogs; D004336:Drug Antagonism; D004386:Duodenum / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects; D014628:Vagotomy
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D013565:Sympatholytics; D012110:Reserpine; D007611:Aprotinin; D010646:Phentolamine
Sugli effetti cardio-vascolari di alcuni anti-fibrinolitici (Trasylol, ac. epsilon-amino-caproico, ac. tranexamico)